ATORVASTATIN CALCIUM 10mg. IP + FENOFIBRATE 160mg. IP

A lipid-lowering therapy that is used in the treatment of high cholesterol and heart attack. Shows a highly beneficial effect on lipid parameters in type 2 diabetes associated with combined hyperlipidemia. (Meenakshi Lella, 2013) Effectively controls the levels of both low-density lipoprotein cholesterol and triglyceride. (Myung Soo Park, 2021) A promising option for the treatment of hypertriglyceridemia and reduces triglyceride levels by 25% to 50% below the baseline. (Myung Soo Park, 2021) An effective and safe alternative to daily therapy in mixed dyslipidemia subjects. (Natarajan Harivenkatesh, 2014) Effectively increases high-density lipoprotein-cholesterol in patients with a wide variety of dyslipidaemias. (H S Malhotra, 2001) Lowers the risk of cardiovascular disease and helps prevent strokes and heart attacks. An appropriate first-line lipid-lowering therapy in numerous groups of patients at low to high risk of coronary heart disease. (H S Malhotra, 2001) More efficacious than lovastatin, pravastatin, fluvastatin, and simvastatin in achieving target low-density lipoprotein-cholesterol levels in patients with coronary heart disease. (H S Malhotra, 2001)